AngioDynamics, Inc.
ANGO
$10.94
$0.282.63%
NASDAQ
| 02/28/2026 | 11/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -1.27% | 4.92% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.27% | 4.92% | |||
| Cost of Revenue | 6.62% | 2.35% | |||
| Gross Profit | -7.38% | 6.99% | |||
| SG&A Expenses | 3.54% | -9.27% | |||
| Depreciation & Amortization | 0.95% | -0.38% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.58% | -2.02% | |||
| Operating Income | -158.19% | 68.47% | |||
| Income Before Tax | -27.02% | 41.36% | |||
| Income Tax Expenses | 340.00% | -107.69% | |||
| Earnings from Continuing Operations | -27.31% | 41.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -27.31% | 41.76% | |||
| EBIT | -158.19% | 68.47% | |||
| EBITDA | -125.73% | 273.43% | |||
| EPS Basic | -27.08% | 42.26% | |||
| Normalized Basic EPS | 43.03% | 66.67% | |||
| EPS Diluted | -27.08% | 42.26% | |||
| Normalized Diluted EPS | 43.03% | 66.67% | |||
| Average Basic Shares Outstanding | 0.13% | 0.89% | |||
| Average Diluted Shares Outstanding | 0.13% | 0.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||